J-Lex

Ozagrel Na injection 40mg syringe “Sawai”

Ozagrel Na injection 40mg syringe “Sawai” contains sodium ozagrel, an antithrombotic agent manufactured by Sawai Pharmaceutical. As a thromboxane A2 synthase inhibitor, it helps reduce the risk of blood clot formation. It is supplied as 40mg 2mL 1 tube, YJ code 3999411G7026.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer